This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Academia Sinica. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Patrick CH Hsieh: Innovator in Drug Delivery Systems
Introduction
Patrick CH Hsieh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of drug delivery, particularly in enhancing the efficacy of treatments for cancer. His innovative approach focuses on the use of specific aptamers to improve drug delivery mechanisms.
Latest Patents
Patrick holds a patent titled "Monocyte-Specific Aptamers and Uses Thereof for Enhancing Drug Delivery to Cancer." This patent represents a breakthrough in targeted therapy, allowing for more effective treatment options for cancer patients.
Career Highlights
Patrick is affiliated with Academia Sinica, a leading research institution in Taiwan. His work at Academia Sinica has positioned him at the forefront of cancer research and drug delivery innovations.
Collaborations
Throughout his career, Patrick has collaborated with notable colleagues, including Kengjung Lee and Hung-chih Chen. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Patrick CH Hsieh is a key figure in the advancement of drug delivery systems, particularly in cancer treatment. His innovative patent and collaborative efforts underscore his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile